Central nervous system AIDS - Related diseases

Acta Neurochirurgica

Volumn 146, Issue 10, 2004, Pages 1071-1074

  Antunes, Francisco ^a,b  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ASEPTIC MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLIC ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SHORT SURVEY; TOXOPLASMOSIS; TREATMENT PLANNING; VIRUS ENCEPHALITIS;

AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HEMATOLOGIC TESTS; HUMANS; POLYMERASE CHAIN REACTION;

EID: 6344254277     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00701-004-0334-0     Document Type: Short Survey

References (27)

1. WHO (2002) Global situation of the AIDS pandemic, end 2002. Weekly Epidemiological Record 77(49): 417-424
2. WHO (2002) HIV/AIDS surveillance and global estimates. Weekly Epidemiological Record 77(50): 425-430
3. HIV and AIDS - United States, 1981-2000 (2001) MMWR; 50(21): 431-434
4. Kirk O, Mocroft A, Katzenstein TL et al (1998) Changes in use of antiretroviral therapy in regions of Europe over time. AIDS 12: 2031-2039
5. Mocroft A, Vella S, Benfield TL et al (1998) Changing patterns of mortality across Europe in patients infected with HIV-1: EuroSIDA study group. Lancet 352: 1725-1730
6. th European AIDS Conference (EACS), Warsaw, Poland. Abstract F916, p 19
7. Jones JL, Hanson DL, Dworkin MR et al (1999) Surveillance for AIDS - defining opportunistic illness, 1992-1997. MMWR CDC Surveillance Summ 48(SS-2): 1-22
8. Price RW, Brew BJ (1997) Central and peripheral nervous system complications. In: Curran J, Essex M, Fauci AS (eds) AIDS-etiology, diagnosis and prevention. Philadelphia, Lippincott-Raven, pp 331-353
9. Dore GJ, McDonald A, Li Y et al (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17: 1539-1545
10. Luft BJ, Hafner R, Korzun A et al (1993) Toxoplasmic encephalitis in patients with the Acquired Immunodeficiency Syndrome. N Engl J Med 329: 995-1000
11. Wallace MR, Rossetti RJ, Olsen PE (1993) Cats and toxoplasmosis risk in HIV-infected adults. JAMA 269: 76-77
12. Israelski DM, Chmiel JS, Poggensee L et al (1993) Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr Hum Retrovirol 6: 414-418
13. Ammassari A, Scoppettuolo G, Murri R et al (1998) Changing disease patterns in focal brain lesion-causing disorders in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 18: 265-371
14. Julander I, Martin C, Lappalainen M et al (2001) Polymerase chain reaction for diagnosis of cerebral toxoplasmosis in cerebrospinal fluid in HIV-positive patients. Scan J Infect Dis 33: 538-541
15. McFadden GI, Roos DS (1999) Apicomplexan plastids as drug targets. Trends Microbiol 7: 328-333
16. Mussini C, Pezzotti P, Goroni A et al (2000) Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type-1-infected patients: the changes in opportunistic prophylaxis study. J Infect Dis 181: 1635-1642
17. Weber T, Trebst C, Frye S et al (1997) Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176: 250-254
18. Kitamura T, Aso Y, Kuniyoshi et al (1990) High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 161: 1128-1133
19. Sundsfjord A, Flaegstad T, Flo R et al (1994) BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 169: 485-490
20. Berger JR, Pall L, Lanska D et al (1998) Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4: 59-68
21. Berger JR, Levy RM, Flomenholft D, Dobbs M (1998) Predictive factors for prolonged survival in acquired immunodeficiency syndrome - associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341-349
22. Fine HA, Mayer RJ (1993) Primary central nervous system lymphoma. Ann Intern Med 119: 1093-1104
23. Castagna A, Cinque P, d'Amico A et al (1997) Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201-thallium single photon emission tomography [letter]. AIDS 11: 1522-1523
24. Antinori A, De Rossi G, Ammassari A et al (1999) Value of combined approach with thallium-201 single photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol 17: 554-560
25. Skiest DJ, Crosby C (2003) Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. AIDS 17: 1787-1793
26. Aboulafia DM (2002) Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma. Clin Infect Dis 34: 1660-1662
27. Raez L, Cabral L, Cai JP et al (1999) Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 15: 713-719